10.21147/j.issn.1000-9604.2018.06.05
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer
30
The authors thank all the patients,physicians and nurses who participated in this study.This study was partly supported by grants from the Chinese National Major Project for New Drug Innovation2015ZX09101005;the Shenzhen municipal science and technology projectJCYJ20120618162903087 and JSGG20140515161400837
2019-03-05(万方平台首次上网日期,不代表论文的发表时间)
共8页
605-612